Dernières nouvelles

Information non disponible

Thavendiranathan P, Negishi T, Somerset E, Negishi K, Penicka M, Lemieux J, Aakhus S, Miyazaki S, Shirazi M, Galderisi M, Marwick TH,

Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy

Article de revue

J Am Coll Cardiol, 77 (4), 2021.

Résumé | Liens:

Kenk M, Grégoire JC, Coté MA, Connelly KA, Davis MK, Dresser G, Ghosh N, Goodman S, Johnson C, Fleshner N

Optimizing screening and management of cardiovascular health in prostate cancer: A review

Article de revue

Can Urol Assoc J, 14 (9), 2020.

Résumé | Liens:

Negishi T, Thavendiranathan P, Negishi K, Marwick TH,

Rationale and Design of the Strain Surveillance of Chemotherapy for Improving Cardiovascular Outcomes: The SUCCOUR Trial

Article de revue

JACC Cardiovasc Imaging, 11 (8), 2018.

Résumé | Liens:

Thavendiranathan P, Negishi T, Coté MA, Penicka M, Massey R, Cho GY, Hristova K, Vinereanu D, Popescu BA, Izumo M, Negishi K, Marwick TH,

Single Versus Standard Multiview Assessment of Global Longitudinal Strain for the Diagnosis of Cardiotoxicity During Cancer Therapy

Article de revue

JACC Cardiovasc Imaging, 11 (8), 2018.

Résumé | Liens:

Constance C, Trudeau L, Jolicoeur EM, Langleben D, Rivard A, Chehayeb R, Côté MA, Delgado D

Cardiologist's perspective to the European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia

Article de revue

Leukemia, 31 (3), 2017.

| Liens:

Lemieux J, Diorio C, Cote MA, Provencher L, Barabe F, Jacob S, St-Pierre C, Demers E, Tremblay-Lemay R, Nadeau-Larochelle C, Michaud A, Laflamme C

Alcohol and HER2 polymorphisms as risk factor for cardiotoxicity in breast cancer treated with trastuzumab

Article de revue

Anticancer Res, 33 (6), 2013.

Résumé | Liens:

Signaler des ajouts ou des modifications